Exelixis
Price & Volume
Stats
See more52W Range | $33.75-$51.63 |
Market Cap | $12.5B |
Shares Short | 30M |
Financials
See moreRevenue (12 Mos) | $2.3B |
Revenue Growth (YoY) | 10% |
Gross Profit (12 Mos) | $2.2B |
Diluted EPS | $3.02 |
News
See moreYahoo Finance • 7 days ago
Assessing Exelixis (EXEL) Valuation After Merck Zanzalintinib Keytruda Colorectal Cancer Collaboration
Yahoo Finance • 22 days ago
Exelixis outlines December PDUFA timeline for ZANZA CRC filing while adding $750M buyback authorization
Yahoo Finance • 30 days ago
Pancreatic Neuroendocrine Tumors Market Research Report 2025-2035, Competitive Analysis of Key Players - Novartis, Pfizer, Exelixis, Merck, Ipsen Pharma, and Takeda Pharma
Yahoo Finance • last month
Why Dow Jones Stock Merck Skidded 4% — And Boosted A Key Rival
About
CEO | Dr. Michael M. Morrissey Ph.D. |
CFO | Mr. Christopher J. Senner |
Address | 1851 Harbor Bay Parkway, Alameda, CA, United States, 94502 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,077 |